C$0.03 0.0 0.0%
Last Trade - 2:30pm
| Market Cap | £3.53m |
| Enterprise Value | £4.81m |
| Revenue | £742k |
| Position in Universe | 2202nd / 2709 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 4.15 | 3.63 | 2.97 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Relevium Technologies Inc. is a Canada-based company that operates in the health and wellness industry, including cannabinoids, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operation of brands and businesses in the health and wellness markets and cannabinoids. Relevium operates through two wholly owned subsidiaries: BGX E-Health LLC (BGX) and Biocannabix Health Corporation (BCX). BGX E-Health LLC, markets dietary supplements, nutraceuticals, sports nutrition, and cosmeceuticals primarily through its Bioganix brand portfolio in the United States (US) and Europe. Biocannabix Health Corporation, which is a biopharma nutraceutical Company focused on delivering pediatric endo-medicinal nutraceuticals for cannabinoid therapy. The Company’s brands are sold at some of the retailers including Walmart.com and Amazon.com.
| Last Annual | June 30th, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | July 19, 2012 |
| Public Since | December 21, 2012 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Consumer Defensives |
| Industry | Food & Tobacco |
| Index | |
| Exchange | TSX Venture Exchange |
| Shares in Issue | 206,970,388 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 1000 Sherbrooke St W Suite 2700, MONTREAL, H3A 3G4, Canada |
| Web | http://www.releviumcorp.com/ |
| Phone | +1 514 8248559 |
| Contact | () |
| Auditors | RSM Canada LLP |
As of 2:30pm, shares in Relevium Technologies Inc are trading at C$0.03, giving the company a market capitalisation of £3.53m. This share price information is delayed by 15 minutes.
Shares in Relevium Technologies Inc are currently trading at C$0.03 and the price has moved by -33.33% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Relevium Technologies Inc price has moved by -51.61% over the past year.
There are no analysts currently covering Relevium Technologies Inc.
Relevium Technologies Inc is scheduled to issue upcoming financial results on the following dates:
Relevium Technologies Inc does not currently pay a dividend.
Relevium Technologies Inc does not currently pay a dividend.
Relevium Technologies Inc does not currently pay a dividend.
To buy shares in Relevium Technologies Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Relevium Technologies Inc are currently trading at C$0.03, giving the company a market capitalisation of £3.53m.
Here are the trading details for Relevium Technologies Inc:
Based on an overall assessment of its quality, value and momentum, Relevium Technologies Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for Relevium Technologies Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Relevium Technologies Inc. Over the past six months, the relative strength of its shares against the market has been -43.4%. At the current price of C$0.03, shares in Relevium Technologies Inc are trading at -11.83% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Relevium Technologies Inc.
Relevium Technologies Inc's management team is headed by:
Here are the top five shareholders of Relevium Technologies Inc based on the size of their shareholding:
